Davidson & Garrard’s Eli Lilly LLY Stock Holding History

Davidson & Garrard’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,727	Closed	-$314K	–	184
2015 Q4	$314K	Sell	3,727 -100	-3%	-$8.3K	0.08%	152
2015 Q3	$320K	Sell	3,827 -940	-20%	-$79.4K	0.08%	152
2015 Q2	$398K	Sell	4,767 -200	-4%	-$15.2K	0.09%	149
2015 Q1	$361K	Hold	4,967	–	–	0.08%	149
2014 Q4	$343K	Sell	4,967 -500	-9%	-$33.8K	0.08%	146
2014 Q3	$355K	Buy	5,467 +548	+11%	+$34.7K	0.09%	147
2014 Q2	$306K	Hold	4,919	–	–	0.07%	151
2014 Q1	$290K	Sell	4,919 -150	-3%	-$8.37K	0.07%	157
2013 Q4	$259K	Hold	5,069	–	–	0.07%	164
2013 Q3	$255K	Sell	5,069 -100	-2%	-$5.24K	0.07%	159
2013 Q2	$254K	Buy	+5,169	New	+$281K	0.08%	148

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Davidson & Garrard's LLY Position: Q1 2016 in Review

Davidson & Garrard sold out of Eli Lilly (LLY) in Q1 2016, closing a stake of 3,727 shares — an estimated $314K sold.

Davidson & Garrard first reported a position in LLY in Q2 2013 and held it in 11 quarters. The position peaked at $398K in Q2 2015. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

Davidson & Garrard reported no remaining Eli Lilly position as of Q1 2016 after selling out during the quarter.
Davidson & Garrard sold 3,727 Eli Lilly shares in Q1 2016, an estimated $314K.
Davidson & Garrard first reported a position in Eli Lilly in Q2 2013 and held it in 11 quarters.
Davidson & Garrard's Eli Lilly position peaked at $398K in Q2 2015.
1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Davidson & Garrard's 13F filing for Q1 2016, filed 5 May 2016.